(Q36815314)

16 August 2017

1 reference

title

The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). (English)

1 reference

16 August 2017

Fecker LF

1

1 reference

16 August 2017

Stockfleth E

2

1 reference

16 August 2017

Nindl I

3

1 reference

16 August 2017

Ulrich C

4

1 reference

16 August 2017

Forschner T

5

1 reference

16 August 2017

Eberle J

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

British Journal of Dermatology

16 August 2017

published in

1 reference

16 August 2017

volume

156 Suppl 3

1 reference

16 August 2017

page(s)

25-33

1 reference

Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Perspectives on cancer immuno-epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

The risk of progression to invasive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Modern treatment modalities in actinic keratoses of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

New insights into the mode of action of anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandins and leukotrienes: advances in eicosanoid biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Role of cyclooxygenase 2 in protein kinase C beta II-mediated colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandins and their regulation in rheumatoid inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 overexpression in human basal cell carcinoma cell line increases antiapoptosis, angiogenesis, and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Raft ceramide in molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

NSAIDs in neuroblastoma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Redox stress regulates cell proliferation and apoptosis of human hepatoma through Akt protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.07856.X

10.1111/J.1365-2133.2007.07856.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference